203 related articles for article (PubMed ID: 16566022)
1. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
Goodin DS
Ann Neurol; 2006 Apr; 59(4):597-605. PubMed ID: 16566022
[TBL] [Abstract][Full Text] [Related]
2. MRI as an outcome in multiple sclerosis clinical trials.
Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
[TBL] [Abstract][Full Text] [Related]
3. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
Zivadinov R
Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
[TBL] [Abstract][Full Text] [Related]
4. The use of MRI as an outcome measure in clinical trials.
Li DK; Li MJ; Traboulsee A; Zhao G; Riddehough A; Paty D
Adv Neurol; 2006; 98():203-26. PubMed ID: 16400836
[TBL] [Abstract][Full Text] [Related]
5. Motor evoked potential: a reliable and objective measure to document the functional consequences of multiple sclerosis? Relation to disability and MRI.
Kalkers NF; Strijers RL; Jasperse MM; Neacsu V; Geurts JJ; Barkhof F; Polman CH; Stam CJ
Clin Neurophysiol; 2007 Jun; 118(6):1332-40. PubMed ID: 17398151
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.
Bar-Zohar D; Agosta F; Goldstaub D; Filippi M
Mult Scler; 2008 Jul; 14(6):719-27. PubMed ID: 18424478
[TBL] [Abstract][Full Text] [Related]
7. Examination of the role of MRI in multiple sclerosis: a problem orientated approach.
McFarland HF
Results Probl Cell Differ; 2010; 51():287-301. PubMed ID: 19960380
[TBL] [Abstract][Full Text] [Related]
8. Methodology of clinical trials in multiple sclerosis.
Mitsikostas DD
Neurol Sci; 2006 Sep; 27 Suppl 5():S362-4. PubMed ID: 16998721
[TBL] [Abstract][Full Text] [Related]
9. [Value of MRI in patients with multiple sclerosis].
Tourbah A
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1124-7. PubMed ID: 11787344
[TBL] [Abstract][Full Text] [Related]
10. Outcome measures in multiple sclerosis clinical trials.
Andersson PB; Goodkin DE
Baillieres Clin Neurol; 1997 Oct; 6(3):409-28. PubMed ID: 10101581
[TBL] [Abstract][Full Text] [Related]
11. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs.
Sormani MP; Bonzano L; Roccatagliata L; De Stefano N
Mult Scler; 2011 May; 17(5):630-3. PubMed ID: 21177320
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis: epidemiology, genetics, classification, natural history, and clinical outcome measures.
Wingerchuk DM; Weinshenker BG
Neuroimaging Clin N Am; 2000 Nov; 10(4):611-24 ,vii. PubMed ID: 11359715
[TBL] [Abstract][Full Text] [Related]
15. MRI in multiple sclerosis.
Simon JH
Phys Med Rehabil Clin N Am; 2005 May; 16(2):383-409, viii. PubMed ID: 15893678
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis: use of MRI in evaluating new therapies.
Miller DH
Semin Neurol; 1998; 18(3):317-25. PubMed ID: 9817536
[TBL] [Abstract][Full Text] [Related]
17. Definition of responder: introduction.
Comi G
Neurol Sci; 2008 Sep; 29 Suppl 2():S209-10. PubMed ID: 18690493
[TBL] [Abstract][Full Text] [Related]
18. Functional magnetic resonance imaging and multiple sclerosis: the evidence for neuronal plasticity.
Buckle GJ
J Neuroimaging; 2005; 15(4 Suppl):82S-93S. PubMed ID: 16385021
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome measures in multiple sclerosis.
Amato MP; Portaccio E
J Neurol Sci; 2007 Aug; 259(1-2):118-22. PubMed ID: 17376487
[TBL] [Abstract][Full Text] [Related]
20. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
Oreja-Guevara C; Charil A; Caputo D; Cavarretta R; Sormani MP; Filippi M
Arch Neurol; 2006 May; 63(5):736-40. PubMed ID: 16682543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
